Tisgenx, Inc.

Tisgenx, Inc. is a medical device company specializing in bovine pericardial tissue patches for surgical repair and reconstruction across multiple surgical disciplines. The company manufactures Invengenx®, a line of glutaraldehyde-crosslinked bovine pericardial patches designed for cardiothoracic, vascular, urological, and general surgical applications. These patches are engineered using the company's proprietary elixP™ tissue fixation technology, a multi-component treatment that achieves complete reduction of antigenicity while preserving natural collagen formation, maintaining tissue flexibility, and promoting endothelialization. The patches feature consistent material thickness, exceptional tensile strength, superior suture retention, and elastic properties suitable for various anatomic challenges. Tisgenx emphasizes material quality with superior handling characteristics and uniform thickness across a wide selection of sizes. The company has supplied 17 hospitals and maintains relationships with certified surgeons. Products are indicated for cardiothoracic repairs, vascular reconstruction, urological applications, and general surgical reconstruction. The company positions itself as offering high-performing bovine pericardial tissue products with enhanced biocompatibility and durability compared to competing solutions.